Redox Polymer Based Reference Electrodes Having An Extended Lifetime For Use In Long Term Amperometric Sensors

• US 20120078070A1
• Filed: 04/20/2011
• Published: 03/29/2012
• Est. Priority Date: 06/02/2008
• Status: Abandoned Application

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Liu, Zenghe, Feldman, Benjamin J., Thomas, Christopher, Ouyang, Tianmei
• Application Number:
  US13/090,533
• Publication Number:
  US 20120078070A1
• Time in Patent Office: Days
• US Class Current: 600/345
• CPC Class Codes: A61B 2562/12 Manufacturing methods specially adapted for producing sensors for in-vivo measurements
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: G01N 27/301 Reference electrodes

Abstract

The present application provides redox polymer based reference electrodes having an extended lifetime that are suitable for use in long term amperometric sensors. Electrochemical sensors equipped with reference electrodes described herein demonstrate considerable stability and extended lifetime in a variety of conditions.

Claims

1-45. -45. (canceled)

46. A method for monitoring concentration of an analyte, the method comprising:

inserting at least a portion of an analyte sensor into a patient, the analyte sensor comprising a working electrode and a reference electrode;

applying a potential of from 150 mV to 190 mV between the working electrode and reference electrode;

collecting data from the analyte sensor; and

determining the analyte concentration from the collected data.

47. The method according to claim 46, wherein the method comprises applying a potential of 150 mV between the working electrode and reference electrode.

48. The method according to claim 46, wherein the method comprises operating the analyte sensor continuously for 140 hours or more.

49. The method according to claim 47, wherein the method comprises operating the analyte sensor continuously for up to 30 days.

50. The method according to claim 46, wherein the analyte sensor responds linearly to an analyte concentration up to at least 30 mM.

51. The method according to claim 46, wherein the method comprises determining the analyte concentration under an oxygen concentration of 40 mm Hg or less.

52. The method according to claim 46, wherein the method comprises inserting the analyte sensor into the subcutaneous tissue of a patient.

53. The method according to claim 46, wherein the reference electrode comprises a redox polymer membrane, the redox polymer membrane comprising a crosslinker and a polymer having the formula:

54. The method according to claim 51, wherein the working electrode comprises a sensing layer comprising an analyte-responsive enzyme and a flux-limiting membrane disposed over the sensing layer.

55. The method according to claim 52, wherein the sensing layer is in contact with a conductive material of only the working electrode.

57. The method according to claim 46, wherein the method comprises applying a potential of 150 mV between the working electrode and reference electrode.

58. The method according to claim 55, wherein the sensing layer is in contact with only the working electrode.

59. The method according to claim 55, wherein the method comprises operating the analyte sensor continuously for 140 hours or more.

60. The method according to claim 57, wherein the method comprises operating the analyte sensor continuously for up to 30 days.

61. The method according to claim 55, wherein the analyte sensor responds linearly to an analyte concentration up to at least 30 mM.

62. The method according to claim 55, wherein the method comprises determining the analyte concentration under an oxygen concentration of 40 mm Hg or less.

63. The method according to claim 55, wherein the method comprises inserting the analyte sensor into the subcutaneous tissue of a patient.

56. A method for monitoring concentration of an analyte, the method comprising:

inserting at least a portion of an analyte sensor into a patient, the analyte sensor comprising;

a working electrode comprising a sensing layer comprising an analyte-responsive enzyme and a flux-limiting membrane disposed over the sensing layer; and

a reference electrode comprising a crosslinker and a polymer having the formula;